EuroPainClinics® Study V (Prospective Observational Study)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02742311

Acronym

EPCSV

Enrollment

500

Registered

2016-04-19

Start date

2021-12-31

Completion date

2021-12-31

Last updated

2022-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Intervertebral Disc Herniation

Brief summary

In this prospective observational trial the effect of the Endoscopic discectomy microinvasive therapy should be examined in (approximately 500) adult patients with low back pain.

Interventions

PROCEDUREEndoscopic disectomy

Endoscopic discectomy is an established method for treatment of lumbar disc herniation. Edoscopic discectomy provides a safe and minimal access corridor for lumbar discectomy. The technique also allows early postoperative mobilization and faster return to work.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* lumbar disc prolapse with unilateral radiculopathy, on clinical evaluation, positive straight leg raise or femoral stretch test, and identification of a single nerve root lesion on MRI

Exclusion criteria

* The exlusion criteria: bilateral root symptoms, double root involvement, cauda equina syndrome and negative MRI Picture for disc herniation, unsigned infomed consent

Design outcomes

Primary

Measure	Time frame	Description
1.Pain as assessed by the Visual analogue scale All acquired information will be noted in to the special anonymous protocol	3 years	All acquired information will be noted in to the special anonymous protocol

Secondary

Measure	Time frame	Description
2.Pain localization as assessed by note of radiating dermatome as neurologic examination	3 years	All acquired information will be noted in to the special anonymous protocol
3.Pain progress as assessed by global pain scale	3 years	All acquired information will be noted in to the special anonymous protocol
4. Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids	3 years	All acquired information will be noted in to the special anonymous protoco

Countries

Slovakia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026